MRSH
NYSE · USDOne year, rebased to 100
MRSH SPY XLF (sector ETF) · weekly closesScore DNA
Each bar is a 0-100 score within the scored universeFlags
Smart-money strip
Each disclosure source on its own window. Filings coinciding is not coordination.Key financials
USD, fiscal year. Stock-based compensation is non-cash; shown against FCF.Valuation
MRSH vs industry median
33 companies in Insurance - BrokersEarnings delivery
Next report 2027-02-04 · consensus EPS $2.20Peers
Market-cap band, not the industry cohort above| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | 12m return |
|---|---|---|---|---|---|---|
| MRSH Marsh & McLennan Companies, | $89.9B | 22.4x | 27.2% | 14.2% | — | — |
| AJG Arthur J. Gallagher & Co. | $65.3B | 41.8x | 6.7% | 8.1% | +26.3% | −8.8% |
| AON Aon plc | $62.1B | 16.0x | 44.7% | 13.0% | +4.9% | −13.9% |
| WLTW Willis Towers Watson Public | $24.7B | 14.3x | 19.8% | 9.3% | +6.7% | — |
| BRO Brown & Brown, Inc. | $23.2B | 19.2x | 10.0% | 17.2% | +39.6% | −20.4% |
| ICE Intercontinental Exchange, I | $90.7B | 22.7x | 13.9% | 35.9% | −0.6% | +5.7% |
| HOOD Robinhood Markets, Inc. | $88.9B | 42.8x | 23.6% | 42.9% | +38.3% | — |
| USB U.S. Bancorp | $91.5B | 11.4x | 12.7% | 19.9% | +3.3% | — |
Recent 8-K filings
Context
Full factsheet
The PDF carries everything on this page plus the cash-allocation waterfall, Form 144 notices, 13F holder detail, dark-pool and short-flow history, seasonality and the moat assessment (None).
Read it in the browser Download (PDF)All fundamentals · 140 measures in 13 categories
Percentile = where MRSH sits among 14 scored companies in Insurance - Brokers (0 = lowest value, 100 = highest). It is a position, not a grade.Valuation
| Measure | MRSH | Industry percentile |
|---|---|---|
| P/E (TTM) | 22.2x | 27th |
| PEG (P/E ÷ 3-yr EPS CAGR) | — | |
| Price / sales | 3.2x | 46th |
| Price / book | 6.1x | 64th |
| Price / tangible book | — | |
| Price / free cash flow | 21.6x | 67th |
| Price / operating cash flow | 20.1x | 67th |
| Enterprise value | $110.4B | 100th |
| EV / sales | 3.9x | 54th |
| EV / EBITDA | 18.3x | 75th |
| EV / EBIT | 21.6x | 73rd |
| EV / free cash flow | 26.6x | 67th |
| Earnings yield | 4.5% | 77th |
| FCF yield | 4.6% | 38th |
| Operating cash flow yield | 5.0% | 38th |
| Graham number (per share) | $76.26 | 67th |
Profitability (TTM)
| Measure | MRSH | Industry percentile |
|---|---|---|
| Gross margin | 42.8% | 38th |
| EBITDA margin | 21.2% | 38th |
| Operating margin | 21.4% | 62nd |
| EBIT margin | 17.9% | 54th |
| Net margin | 14.2% | 69th |
| NOPAT margin | 16.4% | 54th |
| FCF margin | 14.6% | 46th |
| Operating cash flow margin | 15.7% | 46th |
| R&D / revenue | 0.0% | 0th |
| SG&A / revenue | 0.0% | 0th |
| Stock comp / revenue | 1.4% | 42nd |
| Effective tax rate | 23.3% | 69th |
Returns on capital
| Measure | MRSH | Industry percentile |
|---|---|---|
| ROE (on average equity) | 27.5% | 73rd |
| ROA | 6.8% | 69th |
| ROIC | 13.3% | 62nd |
| ROCE | 13.5% | 54th |
| Return on tangible assets | 8.5% | 62nd |
| Cash ROIC (OCF / invested capital) | 12.7% | 36th |
| Gross profitability (GP / assets) | 20.4% | 31st |
| ROIC, 3-yr average | — | |
| ROIC, 5-yr average | — | |
| ROE, 5-yr average | — | |
| Incremental ROIC | — |
Growth
| Measure | MRSH | Industry percentile |
|---|---|---|
| Revenue growth (TTM YoY) | — | |
| Revenue growth (QoQ) | -7.3% | 31st |
| Revenue CAGR, 3 yr | — | |
| Revenue CAGR, 5 yr | — | |
| Gross profit CAGR, 3 yr | — | |
| Operating income CAGR, 3 yr | — | |
| Net income growth (TTM YoY) | — | |
| Net income CAGR, 3 yr | — | |
| EPS growth (TTM YoY) | — | |
| EPS CAGR, 3 yr | — | |
| EPS CAGR, 5 yr | — | |
| FCF growth (TTM YoY) | — | |
| FCF CAGR, 3 yr | — | |
| Operating cash flow CAGR, 3 yr | — | |
| Book value CAGR, 3 yr | — | |
| Dividend CAGR, 3 yr | — | |
| Sustainable growth rate | 15.3% | 56th |
Margin history & stability
| Measure | MRSH | Industry percentile |
|---|---|---|
| Gross margin, 3-yr average | — | |
| Operating margin, 3-yr average | — | |
| Net margin, 3-yr average | — | |
| FCF margin, 3-yr average | — | |
| Revenue stability (0-1) | — | |
| Earnings stability (0-1) | — | |
| Margin stability (0-1) | — |
Liquidity (latest quarter)
| Measure | MRSH | Industry percentile |
|---|---|---|
| Cash & short-term investments | $1.8B | 100th |
| Net cash (− = net debt) | −$20.5B | 0th |
| Working capital | $2.0B | 85th |
| Current ratio | 1.09 | 25th |
| Quick ratio | 1.09 | 33rd |
| Cash ratio (cash + ST investments / current liabilities) | 0.08 | 17th |
| Defensive interval (days) | 623 days | 54th |
Leverage & solvency (latest quarter)
| Measure | MRSH | Industry percentile |
|---|---|---|
| Total debt | $22.3B | 100th |
| Debt / equity | 1.52 | 73rd |
| Net debt / equity | 1.40 | 73rd |
| Debt / assets | 37.3% | 77th |
| Debt / capital | 60.3% | 73rd |
| Debt / EBITDA | 3.71 | 75th |
| Net debt / EBITDA | 3.40 | 83rd |
| Interest coverage (EBIT / interest) | 5.2x | 58th |
| Cash interest coverage | 4.6x | 33rd |
| Debt payback (years of OCF) | 5.0 yrs | 75th |
| Liabilities / assets | 75.1% | 46th |
| IS credit model rating | BBB | |
| Implied credit spread (bps) | 275 | 62nd |
Efficiency
| Measure | MRSH | Industry percentile |
|---|---|---|
| Asset turnover | 0.48 | 46th |
| Fixed asset turnover | 12.77 | 50th |
| Inventory turnover | — | |
| Receivables turnover | 3.7 | 15th |
| Days sales outstanding | 99 days | 85th |
| Days inventory outstanding | — | |
| Days payables outstanding | 80 days | 77th |
| Cash conversion cycle (days) | 18 days | 31st |
| Capex / revenue | 1.1% | 42nd |
| Capex / depreciation | 0.35 | 67th |
| Operating expense ratio | 22.9% | 46th |
Cash flow & earnings quality
| Measure | MRSH | Industry percentile |
|---|---|---|
| Operating cash flow / net income | 1.11 | 9th |
| FCF / net income | 1.03 | 18th |
| FCF / operating cash flow | 92.8% | 55th |
| Capex / operating cash flow | 7.2% | 45th |
| Accruals ratio | -0.7% | 92nd |
| Sloan accruals ratio | 1.5% | 62nd |
| Earnings quality score (0-1) | 1.00 | 64th |
Scores & forensic checks
| Measure | MRSH | Industry percentile |
|---|---|---|
| IS score | 50 | 38th |
| IS profitability | 59 | 62nd |
| IS growth | — | |
| IS value | 51 | 69th |
| IS momentum | — | |
| IS risk (safety) | 100 | 31st |
| IS quality | 62 | 31st |
| IS balance sheet | 35 | 23rd |
| IS earnings quality | 70 | 62nd |
| IS cash flow | 56 | 15th |
| Piotroski F-score (0-9) | 4 | 8th |
| Altman Z-score | — | |
| Beneish M-score | — | |
| Ohlson O-score | −7.73 | 31st |
| IS credit score | 56 | 38th |
Size (TTM)
| Measure | MRSH | Industry percentile |
|---|---|---|
| Market cap | $89.9B | 100th |
| Revenue | $28.5B | 100th |
| EBITDA | $6.0B | 92nd |
| Net income | $4.0B | 100th |
| Free cash flow | $4.2B | 100th |
| Total assets | $59.8B | 92nd |
| Shareholders' equity | $14.7B | 92nd |
| Employees | 95,000 | 100th |
Insider transactions, last 6 months
Form 4 · most recent 12| Date | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | Brennan Katherine SVP and General Counsel |
Option exercise | 1,197 | $83.05 | $99,406 | 8,527 |
| 2026-09-02 | Brennan Katherine SVP and General Counsel |
Open-market sale | 1,197 | $187.90 | $224,915 | 7,330 |
| 2026-09-02 | Brennan Katherine SVP and General Counsel |
Option exercise | 1,197 | $83.05 | $99,406 | 0 |
| 2026-09-02 | Doyle John Q President and CEO |
Option exercise | 16,656 | $73.19 | $1.2M | 133,467 |
| 2026-09-02 | Doyle John Q President and CEO |
Open-market sale | 16,656 | $188.51 | $3.1M | 116,811 |
| 2026-09-02 | Doyle John Q President and CEO |
Option exercise | 16,656 | $73.19 | $1.2M | 16,656 |
| 2026-08-15 | Schapiro Morton O Director |
Award / grant | 219 | — | — | 91,138 |
| 2026-08-15 | Yates Lloyd M Director |
Award / grant | 224 | — | — | 12,680 |
| 2026-08-15 | Lute Jane H Director |
Award / grant | 144 | — | — | 9,103 |
| 2026-08-15 | Mills Steven A Director |
Award / grant | 194 | $188.44 | $36,558 | 5,952 |
| 2026-08-15 | Broussard Bruce D Director |
Award / grant | 192 | $188.44 | $36,181 | 1,617 |
| 2026-08-14 | Schapiro Morton O Director |
Other | 473 | — | — | 90,919 |
Shares acquired vs disposed, by month
acquired disposed · all Form 4 typesBy transaction type, 6 months
| Type | Direction | Filings | Shares | Value |
|---|---|---|---|---|
| Award / grant | Acquired | 19 | 228,475 | $115,138 |
| Open-market sale | Disposed | 6 | 44,166 | $8.2M |
| Option exercise | Acquired | 2 | 17,853 | $1.3M |
| Option exercise | Disposed | 2 | 17,853 | $1.3M |
| Other | Acquired | 14 | 1,690 | — |
Form 144 notices
12 months: 10 notices · 102,393 shares · $18.5M| Filed | Filer | Shares proposed | Est. proceeds |
|---|---|---|---|
| 2026-09-02 | Doyle John Q | 16,656 | $3.1M |
| 2026-09-02 | Brennan Katherine | 1,197 | $224,915 |
| 2026-08-06 | Jones John Jude | 6,500 | $1.2M |
| 2026-07-29 | Beswick Paul | 713 | $141,174 |
Congress trades
12 months: House 20 trades (3 purchases) · Senate 1 (0 purchases)| Traded | Member | Chamber | Type | Amount | Disclosed |
|---|---|---|---|---|---|
| 2026-09-23 | Kevin Hern | House | Sale | $50,001 - $100,000 | 2026-10-14 |
| 2026-09-23 | Kevin Hern | House | Sale (Full) | $50,001 - $100,000 | 2026-10-13 |
| 2026-09-17 | Kevin Hern | House | Sale | $50,001 - $100,000 | 2026-10-14 |
| 2026-09-17 | Kevin Hern | House | Sale (Partial) | $50,001 - $100,000 | 2026-10-13 |
| 2026-01-27 | Tina Smith | Senate | Sale | $50,001 - $100,000 | 2026-01-30 |
Largest 13F holders
Quarter to 2026-06-30, the latest most managers have filed| Manager | Shares | Value | % of shares out |
|---|---|---|---|
| BlackRock, Inc. | 39,502,046 | $6.6B | 8.28% |
| VANGUARD CAPITAL MANAGEMENT LLC | 31,472,575 | $5.2B | 6.60% |
| STATE STREET CORP | 22,401,676 | $3.7B | 4.69% |
| Capital World Investors | 18,122,340 | $3.0B | 3.80% |
| WELLINGTON MANAGEMENT GROUP LLP | 16,975,238 | $2.8B | 3.56% |
| Capital International Investors | 15,729,457 | $2.6B | 3.30% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,510,274 | $2.3B | 2.83% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 13,438,662 | $2.2B | 2.82% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 12,570,512 | $2.1B | 2.63% |
| Capital Research Global Investors | 10,973,649 | $1.8B | 2.30% |
| Artisan Partners Limited Partnership | 7,269,246 | $1.2B | 1.52% |
| FMR LLC | 6,954,123 | $1.2B | 1.46% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 6,507,415 | $1.1B | 1.36% |
| NORGES BANK | 6,255,525 | $1.0B | 1.31% |
| MORGAN STANLEY | 5,918,635 | $986.5M | 1.24% |
Institutional ownership by quarter
Holder changes by quarter
| Quarter | Holders | Ownership | New | Increased | Reduced | Closed |
|---|---|---|---|---|---|---|
| None on file. | ||||||
Schedule 13D / 13G filers
| Filed | Form | Filer | % of class | Shares |
|---|---|---|---|---|
| 2026-04-30 | SCHEDULE 13G | Vanguard Capital Management | 7.5% | 36,418,783 |
| 2026-03-27 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 |
ETFs with the largest holding
| ETF | Weight in fund | Holding value |
|---|---|---|
| VITSX | 0.11% | $2.6B |
| VTI | 0.11% | $2.6B |
| VSMPX | 0.11% | $2.6B |
| VTSAX | 0.11% | $2.6B |
| VOO | 0.12% | $2.1B |
| VFINX | 0.12% | $2.1B |
Share structure
Income statement
Fiscal years, USD| Revenue |
| Cost of revenue |
| Gross profit |
| R&D |
| SG&A |
| Operating income |
| EBITDA |
| Pretax income |
| Income tax |
| Net income |
| EPS, diluted |
| Diluted shares |
Balance sheet
| Cash & short-term investments |
| Receivables |
| Inventory |
| Total current assets |
| PP&E, net |
| Goodwill & intangibles |
| Total assets |
| Accounts payable |
| Total current liabilities |
| Long-term debt |
| Total liabilities |
| Shareholders' equity |
Cash flow statement
Outflows are negative| Net income |
| Depreciation & amortization |
| Stock-based compensation |
| Change in working capital |
| Operating cash flow |
| Capital expenditure |
| Free cash flow |
| Investing cash flow |
| Net debt issued / repaid |
| Buybacks |
| Dividends paid |
Ratio history
Margins on the fiscal-year (TTM at Q4) basis; multiples at each year end| Gross margin |
| Operating margin |
| Net margin |
| FCF margin |
| ROE |
| ROIC |
| ROA |
| Debt / equity |
| Interest coverage |
| Current ratio |
| Revenue growth |
| EPS growth |
| P/E at year end |
| EV / EBITDA at year end |
| FCF yield at year end |
| Dividend payout |
Revenue by segment
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Marsh Insurance Group | — | — | — | — | $31.5B |
| Risk and Insurance Services Segment | $12.1B | $12.6B | $14.1B | $15.4B | — |
| Consulting Segment | $7.8B | $8.1B | $8.7B | $9.1B | — |
| Mercer Consulting Group | — | — | — | — | $6.2B |
| Oliver Wyman Group Consulting Group | — | — | — | — | $3.6B |
| Guy Carpenter Reinsurance Group | — | — | — | — | $2.6B |
Revenue by region · FY2025
Street estimates by fiscal year
Next report 2027-02-04 · consensus EPS $2.20 · these are analysts' numbers, not ours| Fiscal year | Revenue (mean) | Revenue range | EPS (mean) | EPS range | Analysts | P/E on mean EPS |
|---|---|---|---|---|---|---|
| 2026 | $28.6B | $28.6B – $28.8B | $10.46 | $10.33 – $10.56 | 13 | 18.0x |
| 2027 | $30.1B | $29.7B – $30.3B | $11.45 | $10.95 – $11.65 | 14 | 16.4x |
| 2028 | $31.7B | $30.7B – $32.8B | $12.57 | $11.76 – $13.13 | 4 | 15.0x |
Reported vs expected, every quarter on file
| Reported | EPS expected | EPS actual | EPS surprise | Revenue expected | Revenue actual | Revenue surprise |
|---|---|---|---|---|---|---|
| 2026-10-15 | $1.97 | $2.03 | +3.0% | $6.6B | $6.9B | +3.3% |
| 2026-07-21 | $2.88 | $2.96 | +2.8% | $7.3B | $7.4B | +1.7% |
| 2026-04-16 | $3.22 | $3.29 | +2.2% | $7.4B | $7.3B | −1.4% |
| 2026-01-29 | $1.97 | $2.12 | +7.6% | $6.6B | $6.6B | +0.6% |
| 2025-10-16 | $1.78 | $1.85 | +3.9% | $6.3B | $6.4B | +0.4% |
| 2025-07-17 | $2.67 | $2.72 | +1.9% | $6.9B | $7.0B | +0.5% |
| 2025-04-17 | $3.02 | $3.06 | +1.3% | $7.1B | $7.1B | −0.2% |
| 2025-01-30 | $1.76 | $1.87 | +6.3% | $6.0B | $6.1B | +1.8% |
| 2024-10-17 | $1.61 | $1.63 | +1.2% | $5.7B | $5.7B | −0.2% |
| 2024-07-18 | $2.40 | $2.41 | +0.4% | $6.3B | $6.2B | −1.3% |
| 2024-04-18 | $2.80 | $2.89 | +3.2% | $6.4B | $6.5B | +1.4% |
| 2024-01-25 | $1.63 | $1.68 | +3.1% | $5.5B | $5.6B | +0.3% |
| 2023-10-19 | $1.39 | $1.47 | +5.8% | $5.5B | $5.4B | −2.6% |
| 2023-07-20 | $2.12 | $2.20 | +3.8% | $5.8B | $5.9B | +2.0% |
| 2023-04-20 | $2.47 | $2.53 | +2.4% | $5.9B | $5.9B | +1.0% |
| 2023-01-26 | $1.40 | $1.47 | +5.0% | $5.2B | $5.0B | −3.9% |
| 2022-10-20 | $1.14 | $1.18 | +3.5% | $4.9B | $4.8B | −2.2% |
| 2022-07-21 | $1.86 | $1.89 | +1.6% | $5.3B | $5.4B | +0.8% |
| 2022-04-21 | $2.14 | $2.30 | +7.5% | $5.5B | $5.5B | +1.1% |
| 2022-01-27 | $1.34 | $1.36 | +1.5% | $5.5B | $5.1B | −7.1% |
| 2021-10-21 | $0.98 | $1.08 | +10.2% | $4.4B | $4.6B | +3.5% |
| 2021-07-22 | $1.43 | $1.75 | +22.4% | $4.4B | $5.0B | +13.3% |
| 2021-04-27 | $1.71 | $1.99 | +16.4% | $4.8B | $5.1B | +6.1% |
| 2021-01-28 | $1.14 | $1.19 | +4.4% | $4.2B | $4.4B | +5.6% |
Off-exchange (dark pool) volume, weekly
FINRA ATS, $ billions · through the week of 2026-08-31 (FINRA publishes with a delay)| Week of | Notional | Shares | Trades |
|---|---|---|---|
| 2026-08-31 | $472.1M | 2,505,670 | 60,961 |
| 2026-08-24 | $503.1M | 2,606,553 | 61,541 |
| 2026-08-17 | $435.9M | 2,302,934 | 55,587 |
| 2026-08-10 | $367.8M | 1,939,848 | 52,257 |
| 2026-08-03 | $596.7M | 3,116,405 | 66,024 |
| 2026-07-27 | $912.6M | 4,756,255 | 94,487 |
Short-sale share of off-exchange volume
daily 20-day average| Date | Short share | Short volume | Total volume |
|---|---|---|---|
| 2026-10-15 | 41.0% | 592,559 | 1,443,642 |
| 2026-10-14 | 44.3% | 380,377 | 859,530 |
| 2026-10-13 | 38.5% | 614,794 | 1,597,830 |
| 2026-10-12 | 31.6% | 424,609 | 1,343,040 |
| 2026-10-09 | 52.0% | 475,622 | 915,020 |
| 2026-10-08 | 52.2% | 812,064 | 1,556,739 |
| 2026-10-07 | 65.0% | 817,182 | 1,257,285 |
| 2026-10-06 | 47.8% | 342,825 | 716,839 |
| 2026-10-05 | 60.1% | 596,825 | 993,191 |
| 2026-10-02 | 63.7% | 661,888 | 1,039,589 |
Seasonality
Average return by calendar month| Month | Avg return | Up years | Years |
|---|---|---|---|
| None on file. | |||
Indicators
as of 2026-10-16Moving averages and bands
level (price vs level)About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies, Inc. (MRSH) functions as a leading professional services organization, delivering expert guidance and innovative solutions to clients across the vital domains of risk management, strategic planning, and human capital. Based in New York City, the firm maintains a substantial global workforce, employing approximately 65,000 full-time professionals. This entity serves as the parent company for several prominent advisory and consulting brands. These include Marsh, renowned for its insurance brokerage services; Guy Carpenter, a specialist in risk and reinsurance; Mercer, which provides comprehensive human resources and investment-related financial advice; and Oliver Wyman Group, an influential management and economic consultancy. Marsh & McLennan structures its operations into two core business segments. The "Risk and Insurance Services" division encompasses activities such as risk management, along with comprehensive insurance and reinsurance brokerage and services. The "Consulting" division offers a broad spectrum of services, including health, retirement, talent, and investment consulting, as well as specialized advice in management, economics, and brand strategy. The Risk and Insurance Services segment's operations are primarily conducted through Marsh and Guy Carpenter, while Mercer and Oliver Wyman Group are the key contributors to the Consulting segment's offerings.
Key executives
| Name | Title | Pay | Born |
|---|---|---|---|
| John Quinlan Doyle | President, Chief Executive Officer & Director | $7.5M | 1964 |
| Martin C. South | Senior VP & Chief Client Officer | $4.6M | 1965 |
| Dean Klisura | Vice Chair, President & CEO of Marsh Re | $4.3M | 1964 |
| Mark Christopher McGivney | Executive VP, CFO & COO | $4.3M | 1968 |
| Patrick Tomlinson | Vice Chair, President & CEO of Marsh People and Investments | $3.8M | 1971 |
| Jay H. Gelb | Head of Investor Relations of Marsh | — | — |
| John Jones | Senior Vice President, Chief Marketing & Communications Officer | — | 1972 |
| Katherine J. Brennan | Senior Vice President & General Counsel | — | 1979 |
Executive pay, latest proxy
| Executive | Year | Salary | Stock awards | Incentive | Total |
|---|---|---|---|---|---|
| Daniel Glaser President and CEO, | 2017 | $1.4M | $5.3M | $4.3M | $17.0M |
| Companies, and CEO, Marsh | 2017 | $941,667 | $2.3M | $2.5M | $7.4M |
| McLennan Inc. | 2017 | $883,333 | $2.0M | $3.0M | $6.9M |
| Companies, Mark C. Chief Financial Officer, Marsh Inc. President and Executive Consulting Group LLC Vice General Counsel, McLennan | 2017 | $800,000 | $1.1M | $1.6M | $5.2M |
| Marsh McLennan Inc. President | 2017 | $750,000 | $875,120 | $1.6M | $4.4M |
Employees
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| 2026-10-01 | $0.99 | 2026-11-13 |
| 2026-07-23 | $0.99 | 2026-08-14 |
| 2026-04-09 | $0.9 | 2026-05-15 |
| 2026-01-29 | $0.9 | 2026-02-13 |